Bio-Path Holdings(BPTH)
$0.000.00 (0.00%)
BPTH
Bio-Path Holdings financials statements
$0.00
At close:0.00 (0.00%)
Want to see BPTH full AI Analyst Report?
Bio-Path Holdings (BPTH) Ratios
485 Followers
Bio-Path Holdings Ratios
BPTH's free cash flow for Q2 2026 was $-39.00K. For the 2026 fiscal year, BPTH's free cash flow was increased by $0.00 and operating cash flow was $-39.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.08 | 1.15 | 1.60 | 9.27 | 27.29 |
| Quick Ratio | 0.08 | 1.15 | 1.60 | 9.27 | 27.29 |
| Cash Ratio | 0.00 | 0.36 | 0.55 | 6.17 | 24.82 |
| Solvency Ratio | -0.96 | -2.61 | -5.76 | -7.60 | -9.25 |
| Operating Cash Flow Ratio | -0.18 | -3.21 | -6.05 | -8.97 | -10.35 |
| Short-Term Operating Cash Flow Coverage | -3.53 | 0.00 | 0.00 | 0.00 | -120.94 |
| Net Current Asset Value | $ -8.23M | $ 47.00K | $ 263.00K | $ 13.82M | $ 25.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.68 | 0.02 | 0.04 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | -0.06 | 0.54 | 0.26 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | -0.06 | 0.35 | 0.20 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.08 | 25.21 | 7.30 | 1.13 | 1.04 |
| Debt Service Coverage Ratio | -12.42 | 0.00 | 0.00 | 0.00 | -125.35 |
| Interest Coverage Ratio | -39.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.09 | 0.03 | 0.24 | 0.61 | 0.70 |
| Net Debt to EBITDA | -0.06 | 0.11 | 0.06 | 0.74 | 2.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 99.76% | 99.97% |
| EBT Per EBIT | 104.10% | 82.51% | 101.48% | 99.76% | 99.97% |
| Return on Assets (ROA) | -1279.35% | -254.80% | -499.32% | -86.63% | -39.28% |
| Return on Equity (ROE) | 105.51% | -6424.68% | -3645.80% | -97.61% | -41.00% |
| Return on Capital Employed (ROCE) | 101.52% | -2039.46% | -1205.71% | -97.30% | -40.78% |
| Return on Invested Capital (ROIC) | 107.59% | -1787.18% | -1118.07% | -96.57% | -40.52% |
| Return on Tangible Assets | -1279.35% | -254.80% | -499.32% | -86.63% | -39.28% |
| Earnings Yield | -1828.57% | -355.24% | -365.61% | -125.92% | -41.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.02 | 0.12 | 0.39 | 0.27 | 1.52 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 307.84 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -18668.23 | -2924.59 | -937.11 | -1367.72 | -239.12 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 1.19 |
| Days of Payables Outstanding | 18668.23 | 2924.59 | 937.11 | 1367.72 | 240.31 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 1.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.20 | -4.40 | -24.13 | -41.51 | -29.49 |
| Free Cash Flow Per Share | -0.20 | -4.40 | -24.13 | -41.57 | -29.70 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -719.19 | -141.67 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -719.19 | -141.67 |
| Operating Cash Flow Coverage Ratio | -3.45 | -127.41 | -102.08 | -68.34 | -42.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -336.45% | -379.69% | -262.30% | -137.66% | -39.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.05 | -0.28 | -0.27 | -0.79 | -2.43 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.06 | 18.09 | 9.97 | 0.78 | 1.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.30 | -0.26 | -0.38 | -0.73 | -2.54 |
| Price-to-Operating Cash Flow Ratio | -0.30 | -0.26 | -0.38 | -0.73 | -2.56 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.02 | -0.04 | 0.05 |
| Enterprise Value Multiple | -0.11 | -0.17 | -0.22 | -0.06 | -0.18 |
| Enterprise Value | 937.36K | 1.70M | 3.46M | 823.76K | 1.81M |
| EV to EBITDA | -0.11 | -0.17 | -0.22 | -0.06 | -0.18 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.59 | -0.16 | -0.30 | -0.05 | -0.18 |
| EV to Operating Cash Flow | -0.59 | -0.16 | -0.30 | -0.05 | -0.18 |
| Tangible Book Value Per Share | -1.04 | 0.06 | 0.92 | 38.96 | 75.71 |
| Shareholders’ Equity Per Share | -1.04 | 0.06 | 0.92 | 38.96 | 75.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.10 | -4.12 | -33.64 | -38.03 | -31.04 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.04 | 1.00 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.18 | 1.07 | 0.72 | 1.09 | 0.95 |
Currency in USD
